Brief: Xbiotech Data Shows Effective Anti-Virus Activity For True Human Antibodies In Its Candidate Influenza-Covid-19 Therapeutic Cocktail
19/11/2020 13:19
Nov 19 (Reuters) - XBiotech Inc XBIT.O :
* XBIOTECH DATA SHOWS EFFECTIVE ANTI-VIRUS ACTIVITY FOR TRUE
HUMAN
ANTIBODIES IN ITS CANDIDATE INFLUENZA-COVID-19 THERAPEUTIC
COCKTAIL
Source text for Eikon: ID:nGNX375Dkx
Further company coverage: XBIT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke